Current issues and reported findings from the National Survey on Benign Prostatic Hyperplasia.
Fawzy
A
A
Urologic Institute of New Orleans, USA.
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D003937:Diagnosis, Differential; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005194:Family Practice / Q000592:standards; D006801:Humans; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000097:blood / Q000175:diagnosis / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis; D020728:Transurethral Resection of Prostate / Q000379:methods
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D004791:Enzyme Inhibitors; D017430:Prostate-Specific Antigen